Upregulation and downregulation of leptin and adiponectin in ischemic stroke could suggest their importance as future pharmacological targets of atherosclerosis and inflammation; however, this dysregulation due to enzymatic action of CYP2C19 phenotypes needs to be explored further in a large prospective study on ischemic stroke. This evidence concerns the gene ADIPOQ and ischemic stroke.